nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP2E1—Fingolimod—multiple sclerosis	0.169	0.265	CbGbCtD
Mexiletine—CYP2D6—Fingolimod—multiple sclerosis	0.0808	0.126	CbGbCtD
Mexiletine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0797	0.124	CbGbCtD
Mexiletine—CYP3A4—Fingolimod—multiple sclerosis	0.0514	0.0802	CbGbCtD
Mexiletine—CYP2E1—Dexamethasone—multiple sclerosis	0.0413	0.0645	CbGbCtD
Mexiletine—CYP2B6—Dexamethasone—multiple sclerosis	0.0407	0.0636	CbGbCtD
Mexiletine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0331	0.0517	CbGbCtD
Mexiletine—CYP3A4—Triamcinolone—multiple sclerosis	0.0251	0.0392	CbGbCtD
Mexiletine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0241	0.0377	CbGbCtD
Mexiletine—CYP3A4—Betamethasone—multiple sclerosis	0.0215	0.0336	CbGbCtD
Mexiletine—CYP3A4—Prednisolone—multiple sclerosis	0.0212	0.0331	CbGbCtD
Mexiletine—CYP3A4—Prednisone—multiple sclerosis	0.02	0.0313	CbGbCtD
Mexiletine—CYP2D6—Dexamethasone—multiple sclerosis	0.0197	0.0307	CbGbCtD
Mexiletine—CYP3A4—Dexamethasone—multiple sclerosis	0.0125	0.0195	CbGbCtD
Mexiletine—SCN10A—peripheral nervous system—multiple sclerosis	0.00679	0.121	CbGeAlD
Mexiletine—SCN10A—nerve—multiple sclerosis	0.00529	0.0946	CbGeAlD
Mexiletine—SCN2A—brainstem—multiple sclerosis	0.00236	0.0421	CbGeAlD
Mexiletine—AHR—medulla oblongata—multiple sclerosis	0.00203	0.0363	CbGeAlD
Mexiletine—SCN9A—midbrain—multiple sclerosis	0.0019	0.034	CbGeAlD
Mexiletine—AHR—midbrain—multiple sclerosis	0.00186	0.0332	CbGeAlD
Mexiletine—SCN9A—spinal cord—multiple sclerosis	0.00186	0.0332	CbGeAlD
Mexiletine—AHR—spinal cord—multiple sclerosis	0.00181	0.0323	CbGeAlD
Mexiletine—SCN2A—medulla oblongata—multiple sclerosis	0.00164	0.0294	CbGeAlD
Mexiletine—SCN2A—midbrain—multiple sclerosis	0.0015	0.0268	CbGeAlD
Mexiletine—SCN2A—spinal cord—multiple sclerosis	0.00147	0.0262	CbGeAlD
Mexiletine—AHR—cerebellum—multiple sclerosis	0.00144	0.0256	CbGeAlD
Mexiletine—SCN10A—spinal cord—multiple sclerosis	0.00141	0.0252	CbGeAlD
Mexiletine—SCN4A—nervous system—multiple sclerosis	0.0014	0.0249	CbGeAlD
Mexiletine—SCN4A—central nervous system—multiple sclerosis	0.00134	0.024	CbGeAlD
Mexiletine—SCN2A—nervous system—multiple sclerosis	0.00124	0.0221	CbGeAlD
Mexiletine—SCN9A—brain—multiple sclerosis	0.0012	0.0214	CbGeAlD
Mexiletine—SCN10A—nervous system—multiple sclerosis	0.00119	0.0213	CbGeAlD
Mexiletine—SCN2A—central nervous system—multiple sclerosis	0.00119	0.0212	CbGeAlD
Mexiletine—AHR—brain—multiple sclerosis	0.00117	0.0208	CbGeAlD
Mexiletine—SCN2A—cerebellum—multiple sclerosis	0.00116	0.0208	CbGeAlD
Mexiletine—SCN10A—central nervous system—multiple sclerosis	0.00115	0.0205	CbGeAlD
Mexiletine—SCN5A—nervous system—multiple sclerosis	0.00108	0.0193	CbGeAlD
Mexiletine—SCN4A—brain—multiple sclerosis	0.00107	0.019	CbGeAlD
Mexiletine—SCN5A—central nervous system—multiple sclerosis	0.00104	0.0186	CbGeAlD
Mexiletine—SCN2A—brain—multiple sclerosis	0.000944	0.0169	CbGeAlD
Mexiletine—SCN10A—brain—multiple sclerosis	0.00091	0.0163	CbGeAlD
Mexiletine—SCN5A—brain—multiple sclerosis	0.000827	0.0148	CbGeAlD
Mexiletine—SCN9A—Developmental Biology—CD24—multiple sclerosis	0.000785	0.00995	CbGpPWpGaD
Mexiletine—CYP2D6—brainstem—multiple sclerosis	0.000775	0.0138	CbGeAlD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000751	0.00951	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000748	0.00947	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—CD24—multiple sclerosis	0.000722	0.00914	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—CD24—multiple sclerosis	0.000722	0.00914	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—CD24—multiple sclerosis	0.000696	0.00881	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—CD24—multiple sclerosis	0.000686	0.00868	CbGpPWpGaD
Mexiletine—CYP2E1—medulla oblongata—multiple sclerosis	0.000682	0.0122	CbGeAlD
Mexiletine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00068	0.00861	CbGpPWpGaD
Mexiletine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00068	0.00861	CbGpPWpGaD
Mexiletine—CYP2B6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000671	0.0085	CbGpPWpGaD
Mexiletine—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000671	0.0085	CbGpPWpGaD
Mexiletine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000666	0.00844	CbGpPWpGaD
Mexiletine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000666	0.00844	CbGpPWpGaD
Mexiletine—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000657	0.00832	CbGpPWpGaD
Mexiletine—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000657	0.00832	CbGpPWpGaD
Mexiletine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000631	0.00799	CbGpPWpGaD
Mexiletine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000631	0.00799	CbGpPWpGaD
Mexiletine—CYP2E1—spinal cord—multiple sclerosis	0.000608	0.0109	CbGeAlD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000601	0.00761	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000585	0.00741	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000583	0.00739	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000572	0.00724	CbGpPWpGaD
Mexiletine—AHR—Adipogenesis—FAS—multiple sclerosis	0.000559	0.00708	CbGpPWpGaD
Mexiletine—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000551	0.00698	CbGpPWpGaD
Mexiletine—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000551	0.00698	CbGpPWpGaD
Mexiletine—CYP2B6—nervous system—multiple sclerosis	0.000546	0.00975	CbGeAlD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000545	0.0069	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000545	0.0069	CbGpPWpGaD
Mexiletine—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00054	0.00684	CbGpPWpGaD
Mexiletine—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00054	0.00684	CbGpPWpGaD
Mexiletine—CYP2B6—central nervous system—multiple sclerosis	0.000526	0.00939	CbGeAlD
Mexiletine—CYP2E1—nervous system—multiple sclerosis	0.000513	0.00915	CbGeAlD
Mexiletine—CYP2E1—central nervous system—multiple sclerosis	0.000493	0.00881	CbGeAlD
Mexiletine—SCN5A—Developmental Biology—CD24—multiple sclerosis	0.000489	0.0062	CbGpPWpGaD
Mexiletine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000487	0.00616	CbGpPWpGaD
Mexiletine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000487	0.00616	CbGpPWpGaD
Mexiletine—CYP2E1—cerebellum—multiple sclerosis	0.000482	0.00861	CbGeAlD
Mexiletine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000473	0.00599	CbGpPWpGaD
Mexiletine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000473	0.00599	CbGpPWpGaD
Mexiletine—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000466	0.00591	CbGpPWpGaD
Mexiletine—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000466	0.00591	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000455	0.00577	CbGpPWpGaD
Mexiletine—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000431	0.00546	CbGpPWpGaD
Mexiletine—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000423	0.00189	CcSEcCtD
Mexiletine—Depression—Prednisone—multiple sclerosis	0.000423	0.00189	CcSEcCtD
Mexiletine—Visual impairment—Betamethasone—multiple sclerosis	0.000422	0.00188	CcSEcCtD
Mexiletine—Visual impairment—Dexamethasone—multiple sclerosis	0.000422	0.00188	CcSEcCtD
Mexiletine—CYP2B6—brain—multiple sclerosis	0.000417	0.00746	CbGeAlD
Mexiletine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000414	0.00184	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000414	0.00184	CcSEcCtD
Mexiletine—CYP3A4—nervous system—multiple sclerosis	0.000412	0.00737	CbGeAlD
Mexiletine—Malaise—Prednisolone—multiple sclerosis	0.000412	0.00184	CcSEcCtD
Mexiletine—Dysgeusia—Triamcinolone—multiple sclerosis	0.000411	0.00183	CcSEcCtD
Mexiletine—Nausea—Cladribine—multiple sclerosis	0.00041	0.00183	CcSEcCtD
Mexiletine—Syncope—Prednisolone—multiple sclerosis	0.000409	0.00182	CcSEcCtD
Mexiletine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000408	0.00182	CcSEcCtD
Mexiletine—CYP2D6—nervous system—multiple sclerosis	0.000406	0.00725	CbGeAlD
Mexiletine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000405	0.0018	CcSEcCtD
Mexiletine—Somnolence—Mitoxantrone—multiple sclerosis	0.000404	0.0018	CcSEcCtD
Mexiletine—Loss of consciousness—Prednisolone—multiple sclerosis	0.000401	0.00179	CcSEcCtD
Mexiletine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.0004	0.00507	CbGpPWpGaD
Mexiletine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.0004	0.00507	CbGpPWpGaD
Mexiletine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.0004	0.00178	CcSEcCtD
Mexiletine—CYP3A4—central nervous system—multiple sclerosis	0.000397	0.00709	CbGeAlD
Mexiletine—Convulsion—Prednisolone—multiple sclerosis	0.000395	0.00176	CcSEcCtD
Mexiletine—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000395	0.005	CbGpPWpGaD
Mexiletine—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000395	0.005	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—FAS—multiple sclerosis	0.000394	0.00499	CbGpPWpGaD
Mexiletine—Hypertension—Prednisolone—multiple sclerosis	0.000394	0.00176	CcSEcCtD
Mexiletine—CYP2E1—brain—multiple sclerosis	0.000392	0.007	CbGeAlD
Mexiletine—Fatigue—Mitoxantrone—multiple sclerosis	0.000391	0.00175	CcSEcCtD
Mexiletine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000391	0.00174	CcSEcCtD
Mexiletine—Arrhythmia—Betamethasone—multiple sclerosis	0.000391	0.00174	CcSEcCtD
Mexiletine—CYP2D6—central nervous system—multiple sclerosis	0.000391	0.00698	CbGeAlD
Mexiletine—Pancreatitis—Methotrexate—multiple sclerosis	0.00039	0.00174	CcSEcCtD
Mexiletine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000389	0.00174	CcSEcCtD
Mexiletine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000389	0.00173	CcSEcCtD
Mexiletine—Constipation—Mitoxantrone—multiple sclerosis	0.000388	0.00173	CcSEcCtD
Mexiletine—Pain—Mitoxantrone—multiple sclerosis	0.000388	0.00173	CcSEcCtD
Mexiletine—Bradycardia—Prednisone—multiple sclerosis	0.000388	0.00173	CcSEcCtD
Mexiletine—Alopecia—Betamethasone—multiple sclerosis	0.000387	0.00172	CcSEcCtD
Mexiletine—Alopecia—Dexamethasone—multiple sclerosis	0.000387	0.00172	CcSEcCtD
Mexiletine—Diarrhoea—Azathioprine—multiple sclerosis	0.000384	0.00171	CcSEcCtD
Mexiletine—Discomfort—Prednisolone—multiple sclerosis	0.000384	0.00171	CcSEcCtD
Mexiletine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000383	0.00485	CbGpPWpGaD
Mexiletine—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000383	0.00485	CbGpPWpGaD
Mexiletine—CYP2D6—cerebellum—multiple sclerosis	0.000382	0.00682	CbGeAlD
Mexiletine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000381	0.0017	CcSEcCtD
Mexiletine—Hallucination—Prednisone—multiple sclerosis	0.000379	0.00169	CcSEcCtD
Mexiletine—Malaise—Triamcinolone—multiple sclerosis	0.000378	0.00169	CcSEcCtD
Mexiletine—Malaise—Methylprednisolone—multiple sclerosis	0.000378	0.00168	CcSEcCtD
Mexiletine—Syncope—Triamcinolone—multiple sclerosis	0.000376	0.00168	CcSEcCtD
Mexiletine—Syncope—Methylprednisolone—multiple sclerosis	0.000376	0.00167	CcSEcCtD
Mexiletine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000374	0.00167	CcSEcCtD
Mexiletine—Oedema—Prednisolone—multiple sclerosis	0.000372	0.00166	CcSEcCtD
Mexiletine—Neutropenia—Methotrexate—multiple sclerosis	0.000372	0.00166	CcSEcCtD
Mexiletine—Dizziness—Azathioprine—multiple sclerosis	0.000371	0.00166	CcSEcCtD
Mexiletine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000371	0.00166	CcSEcCtD
Mexiletine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000369	0.00164	CcSEcCtD
Mexiletine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000368	0.00164	CcSEcCtD
Mexiletine—Shock—Prednisolone—multiple sclerosis	0.000366	0.00163	CcSEcCtD
Mexiletine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000366	0.00163	CcSEcCtD
Mexiletine—Convulsion—Triamcinolone—multiple sclerosis	0.000364	0.00162	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—PRNP—multiple sclerosis	0.000363	0.0046	CbGpPWpGaD
Mexiletine—Convulsion—Methylprednisolone—multiple sclerosis	0.000363	0.00162	CcSEcCtD
Mexiletine—Hypertension—Triamcinolone—multiple sclerosis	0.000362	0.00162	CcSEcCtD
Mexiletine—Hypertension—Methylprednisolone—multiple sclerosis	0.000362	0.00161	CcSEcCtD
Mexiletine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00036	0.00161	CcSEcCtD
Mexiletine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000359	0.0016	CcSEcCtD
Mexiletine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000359	0.0016	CcSEcCtD
Mexiletine—Vomiting—Azathioprine—multiple sclerosis	0.000357	0.00159	CcSEcCtD
Mexiletine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000356	0.00159	CcSEcCtD
Mexiletine—Drowsiness—Methotrexate—multiple sclerosis	0.000355	0.00158	CcSEcCtD
Mexiletine—Rash—Azathioprine—multiple sclerosis	0.000354	0.00158	CcSEcCtD
Mexiletine—Dermatitis—Azathioprine—multiple sclerosis	0.000354	0.00158	CcSEcCtD
Mexiletine—Depression—Methotrexate—multiple sclerosis	0.000354	0.00158	CcSEcCtD
Mexiletine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000353	0.00158	CcSEcCtD
Mexiletine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000353	0.00158	CcSEcCtD
Mexiletine—Discomfort—Triamcinolone—multiple sclerosis	0.000353	0.00157	CcSEcCtD
Mexiletine—Discomfort—Methylprednisolone—multiple sclerosis	0.000352	0.00157	CcSEcCtD
Mexiletine—Headache—Azathioprine—multiple sclerosis	0.000352	0.00157	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000352	0.00157	CcSEcCtD
Mexiletine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00035	0.00444	CbGpPWpGaD
Mexiletine—Dry mouth—Triamcinolone—multiple sclerosis	0.000349	0.00156	CcSEcCtD
Mexiletine—Confusional state—Methylprednisolone—multiple sclerosis	0.000345	0.00154	CcSEcCtD
Mexiletine—Malaise—Dexamethasone—multiple sclerosis	0.000343	0.00153	CcSEcCtD
Mexiletine—Malaise—Betamethasone—multiple sclerosis	0.000343	0.00153	CcSEcCtD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000343	0.00435	CbGpPWpGaD
Mexiletine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000343	0.00435	CbGpPWpGaD
Mexiletine—Oedema—Triamcinolone—multiple sclerosis	0.000343	0.00153	CcSEcCtD
Mexiletine—Syncope—Betamethasone—multiple sclerosis	0.000341	0.00152	CcSEcCtD
Mexiletine—Syncope—Dexamethasone—multiple sclerosis	0.000341	0.00152	CcSEcCtD
Mexiletine—Arrhythmia—Prednisone—multiple sclerosis	0.00034	0.00152	CcSEcCtD
Mexiletine—Shock—Triamcinolone—multiple sclerosis	0.000337	0.0015	CcSEcCtD
Mexiletine—Alopecia—Prednisone—multiple sclerosis	0.000337	0.0015	CcSEcCtD
Mexiletine—Shock—Methylprednisolone—multiple sclerosis	0.000336	0.0015	CcSEcCtD
Mexiletine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000335	0.00149	CcSEcCtD
Mexiletine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000335	0.00149	CcSEcCtD
Mexiletine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000334	0.00149	CcSEcCtD
Mexiletine—Paraesthesia—Prednisolone—multiple sclerosis	0.000334	0.00149	CcSEcCtD
Mexiletine—SCN4A—Axon guidance—PRNP—multiple sclerosis	0.000334	0.00423	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—PRNP—multiple sclerosis	0.000334	0.00423	CbGpPWpGaD
Mexiletine—Nausea—Azathioprine—multiple sclerosis	0.000334	0.00149	CcSEcCtD
Mexiletine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000331	0.00148	CcSEcCtD
Mexiletine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000331	0.00148	CcSEcCtD
Mexiletine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00033	0.00147	CcSEcCtD
Mexiletine—Convulsion—Dexamethasone—multiple sclerosis	0.00033	0.00147	CcSEcCtD
Mexiletine—Convulsion—Betamethasone—multiple sclerosis	0.00033	0.00147	CcSEcCtD
Mexiletine—Hypertension—Betamethasone—multiple sclerosis	0.000329	0.00147	CcSEcCtD
Mexiletine—Hypertension—Dexamethasone—multiple sclerosis	0.000329	0.00147	CcSEcCtD
Mexiletine—Asthenia—Mitoxantrone—multiple sclerosis	0.000326	0.00145	CcSEcCtD
Mexiletine—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000325	0.00411	CbGpPWpGaD
Mexiletine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000325	0.00411	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—PRNP—multiple sclerosis	0.000322	0.00407	CbGpPWpGaD
Mexiletine—Discomfort—Dexamethasone—multiple sclerosis	0.00032	0.00143	CcSEcCtD
Mexiletine—Discomfort—Betamethasone—multiple sclerosis	0.00032	0.00143	CcSEcCtD
Mexiletine—Hypotension—Methylprednisolone—multiple sclerosis	0.000319	0.00142	CcSEcCtD
Mexiletine—Pain—Prednisolone—multiple sclerosis	0.000318	0.00142	CcSEcCtD
Mexiletine—Hepatitis—Methotrexate—multiple sclerosis	0.000318	0.00142	CcSEcCtD
Mexiletine—Pharyngitis—Methotrexate—multiple sclerosis	0.000316	0.00141	CcSEcCtD
Mexiletine—Vision blurred—Prednisone—multiple sclerosis	0.000313	0.00139	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000312	0.00139	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000311	0.00139	CcSEcCtD
Mexiletine—Oedema—Betamethasone—multiple sclerosis	0.000311	0.00139	CcSEcCtD
Mexiletine—Oedema—Dexamethasone—multiple sclerosis	0.000311	0.00139	CcSEcCtD
Mexiletine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000311	0.00139	CcSEcCtD
Mexiletine—CYP2D6—brain—multiple sclerosis	0.00031	0.00554	CbGeAlD
Mexiletine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000309	0.00391	CbGpPWpGaD
Mexiletine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000309	0.00391	CbGpPWpGaD
Mexiletine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000308	0.00137	CcSEcCtD
Mexiletine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000308	0.00137	CcSEcCtD
Mexiletine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000307	0.00137	CcSEcCtD
Mexiletine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000307	0.00137	CcSEcCtD
Mexiletine—Visual impairment—Methotrexate—multiple sclerosis	0.000307	0.00137	CcSEcCtD
Mexiletine—Shock—Dexamethasone—multiple sclerosis	0.000306	0.00136	CcSEcCtD
Mexiletine—Shock—Betamethasone—multiple sclerosis	0.000306	0.00136	CcSEcCtD
Mexiletine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000305	0.00136	CcSEcCtD
Mexiletine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000305	0.00386	CbGpPWpGaD
Mexiletine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000305	0.00386	CbGpPWpGaD
Mexiletine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000304	0.00136	CcSEcCtD
Mexiletine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000304	0.00136	CcSEcCtD
Mexiletine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000301	0.00134	CcSEcCtD
Mexiletine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000301	0.00134	CcSEcCtD
Mexiletine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000301	0.00134	CcSEcCtD
Mexiletine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.0003	0.00134	CcSEcCtD
Mexiletine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.0003	0.00134	CcSEcCtD
Mexiletine—Malaise—Prednisone—multiple sclerosis	0.000299	0.00133	CcSEcCtD
Mexiletine—Syncope—Prednisone—multiple sclerosis	0.000297	0.00133	CcSEcCtD
Mexiletine—Tinnitus—Methotrexate—multiple sclerosis	0.000297	0.00132	CcSEcCtD
Mexiletine—Fatigue—Triamcinolone—multiple sclerosis	0.000295	0.00132	CcSEcCtD
Mexiletine—Fatigue—Methylprednisolone—multiple sclerosis	0.000295	0.00131	CcSEcCtD
Mexiletine—Pain—Triamcinolone—multiple sclerosis	0.000293	0.00131	CcSEcCtD
Mexiletine—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000293	0.00371	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	0.000293	0.00371	CbGpPWpGaD
Mexiletine—Loss of consciousness—Prednisone—multiple sclerosis	0.000291	0.0013	CcSEcCtD
Mexiletine—Hypotension—Dexamethasone—multiple sclerosis	0.00029	0.00129	CcSEcCtD
Mexiletine—Hypotension—Betamethasone—multiple sclerosis	0.00029	0.00129	CcSEcCtD
Mexiletine—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000289	0.00366	CbGpPWpGaD
Mexiletine—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000289	0.00366	CbGpPWpGaD
Mexiletine—Vomiting—Mitoxantrone—multiple sclerosis	0.000289	0.00129	CcSEcCtD
Mexiletine—Convulsion—Prednisone—multiple sclerosis	0.000287	0.00128	CcSEcCtD
Mexiletine—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000287	0.00363	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000287	0.00363	CbGpPWpGaD
Mexiletine—Hypertension—Prednisone—multiple sclerosis	0.000286	0.00128	CcSEcCtD
Mexiletine—Rash—Mitoxantrone—multiple sclerosis	0.000286	0.00128	CcSEcCtD
Mexiletine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000286	0.00128	CcSEcCtD
Mexiletine—Headache—Mitoxantrone—multiple sclerosis	0.000284	0.00127	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000283	0.00126	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000283	0.00126	CcSEcCtD
Mexiletine—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000283	0.00358	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000283	0.00358	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—PTPRC—multiple sclerosis	0.000282	0.00358	CbGpPWpGaD
Mexiletine—Arthralgia—Prednisone—multiple sclerosis	0.000282	0.00126	CcSEcCtD
Mexiletine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000282	0.00126	CcSEcCtD
Mexiletine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000282	0.00126	CcSEcCtD
Mexiletine—Alopecia—Methotrexate—multiple sclerosis	0.000281	0.00125	CcSEcCtD
Mexiletine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000279	0.00125	CcSEcCtD
Mexiletine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000279	0.00124	CcSEcCtD
Mexiletine—Paraesthesia—Betamethasone—multiple sclerosis	0.000279	0.00124	CcSEcCtD
Mexiletine—Discomfort—Prednisone—multiple sclerosis	0.000279	0.00124	CcSEcCtD
Mexiletine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000277	0.00351	CbGpPWpGaD
Mexiletine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000274	0.00122	CcSEcCtD
Mexiletine—AHR—Adipogenesis—STAT3—multiple sclerosis	0.000274	0.00347	CbGpPWpGaD
Mexiletine—Dyspepsia—Betamethasone—multiple sclerosis	0.000274	0.00122	CcSEcCtD
Mexiletine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000274	0.00122	CcSEcCtD
Mexiletine—Dysgeusia—Methotrexate—multiple sclerosis	0.000271	0.00121	CcSEcCtD
Mexiletine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000271	0.00121	CcSEcCtD
Mexiletine—Oedema—Prednisone—multiple sclerosis	0.000271	0.00121	CcSEcCtD
Mexiletine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00027	0.0012	CcSEcCtD
Mexiletine—Nausea—Mitoxantrone—multiple sclerosis	0.00027	0.0012	CcSEcCtD
Mexiletine—Fatigue—Dexamethasone—multiple sclerosis	0.000268	0.00119	CcSEcCtD
Mexiletine—Fatigue—Betamethasone—multiple sclerosis	0.000268	0.00119	CcSEcCtD
Mexiletine—Shock—Prednisone—multiple sclerosis	0.000266	0.00119	CcSEcCtD
Mexiletine—Pain—Dexamethasone—multiple sclerosis	0.000266	0.00119	CcSEcCtD
Mexiletine—Pain—Betamethasone—multiple sclerosis	0.000266	0.00119	CcSEcCtD
Mexiletine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000262	0.00117	CcSEcCtD
Mexiletine—Vision blurred—Methotrexate—multiple sclerosis	0.000261	0.00116	CcSEcCtD
Mexiletine—SCN4A—Axon guidance—PTPRC—multiple sclerosis	0.000259	0.00329	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—PTPRC—multiple sclerosis	0.000259	0.00329	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—PRNP—multiple sclerosis	0.000259	0.00328	CbGpPWpGaD
Mexiletine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000257	0.00115	CcSEcCtD
Mexiletine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000256	0.00114	CcSEcCtD
Mexiletine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000256	0.00114	CcSEcCtD
Mexiletine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000254	0.00113	CcSEcCtD
Mexiletine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000254	0.00113	CcSEcCtD
Mexiletine—AHR—Adipogenesis—TGFB1—multiple sclerosis	0.000254	0.00322	CbGpPWpGaD
Mexiletine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000252	0.00113	CcSEcCtD
Mexiletine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000252	0.00112	CcSEcCtD
Mexiletine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000251	0.00317	CbGpPWpGaD
Mexiletine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000251	0.00317	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—PTPRC—multiple sclerosis	0.00025	0.00317	CbGpPWpGaD
Mexiletine—Malaise—Methotrexate—multiple sclerosis	0.00025	0.00111	CcSEcCtD
Mexiletine—Leukopenia—Methotrexate—multiple sclerosis	0.000248	0.00111	CcSEcCtD
Mexiletine—Tocainide—ALB—multiple sclerosis	0.000248	1	CrCbGaD
Mexiletine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000247	0.0011	CcSEcCtD
Mexiletine—Dizziness—Prednisolone—multiple sclerosis	0.000246	0.0011	CcSEcCtD
Mexiletine—Asthenia—Triamcinolone—multiple sclerosis	0.000246	0.0011	CcSEcCtD
Mexiletine—Abdominal pain—Betamethasone—multiple sclerosis	0.000246	0.0011	CcSEcCtD
Mexiletine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000246	0.0011	CcSEcCtD
Mexiletine—Body temperature increased—Betamethasone—multiple sclerosis	0.000246	0.0011	CcSEcCtD
Mexiletine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000246	0.0011	CcSEcCtD
Mexiletine—Asthenia—Methylprednisolone—multiple sclerosis	0.000245	0.00109	CcSEcCtD
Mexiletine—Paraesthesia—Prednisone—multiple sclerosis	0.000243	0.00108	CcSEcCtD
Mexiletine—Convulsion—Methotrexate—multiple sclerosis	0.00024	0.00107	CcSEcCtD
Mexiletine—Dyspepsia—Prednisone—multiple sclerosis	0.000238	0.00106	CcSEcCtD
Mexiletine—SCN2A—Developmental Biology—PRNP—multiple sclerosis	0.000238	0.00302	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—PRNP—multiple sclerosis	0.000238	0.00302	CbGpPWpGaD
Mexiletine—AHR—Adipogenesis—TNF—multiple sclerosis	0.000237	0.003	CbGpPWpGaD
Mexiletine—Chest pain—Methotrexate—multiple sclerosis	0.000236	0.00105	CcSEcCtD
Mexiletine—Arthralgia—Methotrexate—multiple sclerosis	0.000236	0.00105	CcSEcCtD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000236	0.00298	CbGpPWpGaD
Mexiletine—Rash—Prednisolone—multiple sclerosis	0.000235	0.00105	CcSEcCtD
Mexiletine—Dermatitis—Prednisolone—multiple sclerosis	0.000235	0.00105	CcSEcCtD
Mexiletine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000234	0.00104	CcSEcCtD
Mexiletine—Fatigue—Prednisone—multiple sclerosis	0.000233	0.00104	CcSEcCtD
Mexiletine—Headache—Prednisolone—multiple sclerosis	0.000233	0.00104	CcSEcCtD
Mexiletine—Discomfort—Methotrexate—multiple sclerosis	0.000233	0.00104	CcSEcCtD
Mexiletine—Constipation—Prednisone—multiple sclerosis	0.000231	0.00103	CcSEcCtD
Mexiletine—SCN10A—Developmental Biology—PRNP—multiple sclerosis	0.00023	0.00291	CbGpPWpGaD
Mexiletine—Confusional state—Methotrexate—multiple sclerosis	0.000228	0.00102	CcSEcCtD
Mexiletine—Dizziness—Triamcinolone—multiple sclerosis	0.000226	0.00101	CcSEcCtD
Mexiletine—SCN5A—Axon guidance—PRNP—multiple sclerosis	0.000226	0.00286	CbGpPWpGaD
Mexiletine—Dizziness—Methylprednisolone—multiple sclerosis	0.000226	0.00101	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	0.000226	0.00286	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000225	0.00285	CbGpPWpGaD
Mexiletine—Feeling abnormal—Prednisone—multiple sclerosis	0.000223	0.000994	CcSEcCtD
Mexiletine—Asthenia—Dexamethasone—multiple sclerosis	0.000223	0.000994	CcSEcCtD
Mexiletine—Asthenia—Betamethasone—multiple sclerosis	0.000223	0.000994	CcSEcCtD
Mexiletine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000221	0.000988	CcSEcCtD
Mexiletine—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000221	0.0028	CbGpPWpGaD
Mexiletine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000221	0.000987	CcSEcCtD
Mexiletine—Nausea—Prednisolone—multiple sclerosis	0.000221	0.000986	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	0.000221	0.0028	CbGpPWpGaD
Mexiletine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000219	0.000975	CcSEcCtD
Mexiletine—Vomiting—Triamcinolone—multiple sclerosis	0.000218	0.000971	CcSEcCtD
Mexiletine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—multiple sclerosis	0.000217	0.00275	CbGpPWpGaD
Mexiletine—Vomiting—Methylprednisolone—multiple sclerosis	0.000217	0.000969	CcSEcCtD
Mexiletine—Rash—Triamcinolone—multiple sclerosis	0.000216	0.000963	CcSEcCtD
Mexiletine—Dermatitis—Triamcinolone—multiple sclerosis	0.000216	0.000962	CcSEcCtD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000216	0.00273	CbGpPWpGaD
Mexiletine—Rash—Methylprednisolone—multiple sclerosis	0.000215	0.000961	CcSEcCtD
Mexiletine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000215	0.00096	CcSEcCtD
Mexiletine—Headache—Triamcinolone—multiple sclerosis	0.000215	0.000957	CcSEcCtD
Mexiletine—Headache—Methylprednisolone—multiple sclerosis	0.000214	0.000955	CcSEcCtD
Mexiletine—Body temperature increased—Prednisone—multiple sclerosis	0.000214	0.000954	CcSEcCtD
Mexiletine—Abdominal pain—Prednisone—multiple sclerosis	0.000214	0.000954	CcSEcCtD
Mexiletine—SCN9A—L1CAM interactions—MAPK1—multiple sclerosis	0.000213	0.00269	CbGpPWpGaD
Mexiletine—Diarrhoea—Betamethasone—multiple sclerosis	0.000213	0.000948	CcSEcCtD
Mexiletine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000213	0.000948	CcSEcCtD
Mexiletine—Hypotension—Methotrexate—multiple sclerosis	0.000211	0.000942	CcSEcCtD
Mexiletine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000206	0.00261	CbGpPWpGaD
Mexiletine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000206	0.000919	CcSEcCtD
Mexiletine—Dizziness—Dexamethasone—multiple sclerosis	0.000206	0.000916	CcSEcCtD
Mexiletine—Dizziness—Betamethasone—multiple sclerosis	0.000206	0.000916	CcSEcCtD
Mexiletine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000204	0.00258	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000204	0.00258	CbGpPWpGaD
Mexiletine—Nausea—Triamcinolone—multiple sclerosis	0.000203	0.000907	CcSEcCtD
Mexiletine—Paraesthesia—Methotrexate—multiple sclerosis	0.000203	0.000906	CcSEcCtD
Mexiletine—Nausea—Methylprednisolone—multiple sclerosis	0.000203	0.000905	CcSEcCtD
Mexiletine—Dyspnoea—Methotrexate—multiple sclerosis	0.000202	0.000899	CcSEcCtD
Mexiletine—SCN9A—Developmental Biology—PTPRC—multiple sclerosis	0.000201	0.00255	CbGpPWpGaD
Mexiletine—Somnolence—Methotrexate—multiple sclerosis	0.000201	0.000897	CcSEcCtD
Mexiletine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000201	0.00254	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000201	0.00254	CbGpPWpGaD
Mexiletine—Hypersensitivity—Prednisone—multiple sclerosis	0.000199	0.000889	CcSEcCtD
Mexiletine—Dyspepsia—Methotrexate—multiple sclerosis	0.000199	0.000888	CcSEcCtD
Mexiletine—Vomiting—Betamethasone—multiple sclerosis	0.000198	0.000881	CcSEcCtD
Mexiletine—Vomiting—Dexamethasone—multiple sclerosis	0.000198	0.000881	CcSEcCtD
Mexiletine—Rash—Dexamethasone—multiple sclerosis	0.000196	0.000874	CcSEcCtD
Mexiletine—Rash—Betamethasone—multiple sclerosis	0.000196	0.000874	CcSEcCtD
Mexiletine—Dermatitis—Dexamethasone—multiple sclerosis	0.000196	0.000873	CcSEcCtD
Mexiletine—Dermatitis—Betamethasone—multiple sclerosis	0.000196	0.000873	CcSEcCtD
Mexiletine—SCN4A—L1CAM interactions—MAPK1—multiple sclerosis	0.000196	0.00248	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—MAPK1—multiple sclerosis	0.000196	0.00248	CbGpPWpGaD
Mexiletine—Fatigue—Methotrexate—multiple sclerosis	0.000195	0.00087	CcSEcCtD
Mexiletine—Headache—Dexamethasone—multiple sclerosis	0.000195	0.000868	CcSEcCtD
Mexiletine—Headache—Betamethasone—multiple sclerosis	0.000195	0.000868	CcSEcCtD
Mexiletine—Asthenia—Prednisone—multiple sclerosis	0.000194	0.000866	CcSEcCtD
Mexiletine—Pain—Methotrexate—multiple sclerosis	0.000193	0.000862	CcSEcCtD
Mexiletine—AHR—Adipogenesis—IL6—multiple sclerosis	0.000191	0.00242	CbGpPWpGaD
Mexiletine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.00019	0.00241	CbGpPWpGaD
Mexiletine—SCN10A—L1CAM interactions—MAPK1—multiple sclerosis	0.000189	0.00239	CbGpPWpGaD
Mexiletine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000188	0.00238	CbGpPWpGaD
Mexiletine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000186	0.000831	CcSEcCtD
Mexiletine—Diarrhoea—Prednisone—multiple sclerosis	0.000185	0.000826	CcSEcCtD
Mexiletine—SCN4A—Developmental Biology—PTPRC—multiple sclerosis	0.000185	0.00234	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—PTPRC—multiple sclerosis	0.000185	0.00234	CbGpPWpGaD
Mexiletine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000185	0.000825	CcSEcCtD
Mexiletine—Nausea—Dexamethasone—multiple sclerosis	0.000185	0.000823	CcSEcCtD
Mexiletine—Nausea—Betamethasone—multiple sclerosis	0.000185	0.000823	CcSEcCtD
Mexiletine—Dizziness—Prednisone—multiple sclerosis	0.000179	0.000798	CcSEcCtD
Mexiletine—Body temperature increased—Methotrexate—multiple sclerosis	0.000179	0.000797	CcSEcCtD
Mexiletine—Abdominal pain—Methotrexate—multiple sclerosis	0.000179	0.000797	CcSEcCtD
Mexiletine—SCN10A—Developmental Biology—PTPRC—multiple sclerosis	0.000179	0.00226	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—PTPRC—multiple sclerosis	0.000176	0.00223	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000172	0.00218	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000172	0.00218	CbGpPWpGaD
Mexiletine—Vomiting—Prednisone—multiple sclerosis	0.000172	0.000767	CcSEcCtD
Mexiletine—Rash—Prednisone—multiple sclerosis	0.000171	0.000761	CcSEcCtD
Mexiletine—Dermatitis—Prednisone—multiple sclerosis	0.00017	0.00076	CcSEcCtD
Mexiletine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00017	0.00215	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00017	0.00215	CbGpPWpGaD
Mexiletine—Headache—Prednisone—multiple sclerosis	0.00017	0.000756	CcSEcCtD
Mexiletine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000167	0.000743	CcSEcCtD
Mexiletine—Asthenia—Methotrexate—multiple sclerosis	0.000162	0.000724	CcSEcCtD
Mexiletine—SCN5A—Developmental Biology—PRNP—multiple sclerosis	0.000161	0.00204	CbGpPWpGaD
Mexiletine—Nausea—Prednisone—multiple sclerosis	0.000161	0.000717	CcSEcCtD
Mexiletine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000159	0.00202	CbGpPWpGaD
Mexiletine—Diarrhoea—Methotrexate—multiple sclerosis	0.000155	0.00069	CcSEcCtD
Mexiletine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000153	0.00194	CbGpPWpGaD
Mexiletine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00015	0.0019	CbGpPWpGaD
Mexiletine—Dizziness—Methotrexate—multiple sclerosis	0.00015	0.000667	CcSEcCtD
Mexiletine—Vomiting—Methotrexate—multiple sclerosis	0.000144	0.000641	CcSEcCtD
Mexiletine—Rash—Methotrexate—multiple sclerosis	0.000143	0.000636	CcSEcCtD
Mexiletine—Dermatitis—Methotrexate—multiple sclerosis	0.000142	0.000635	CcSEcCtD
Mexiletine—Headache—Methotrexate—multiple sclerosis	0.000142	0.000632	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—IL6—multiple sclerosis	0.000135	0.00171	CbGpPWpGaD
Mexiletine—Nausea—Methotrexate—multiple sclerosis	0.000134	0.000599	CcSEcCtD
Mexiletine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000133	0.00169	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000133	0.00169	CbGpPWpGaD
Mexiletine—SCN5A—L1CAM interactions—MAPK1—multiple sclerosis	0.000133	0.00168	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000131	0.00166	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000131	0.00166	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—TYK2—multiple sclerosis	0.000126	0.0016	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—PTPRC—multiple sclerosis	0.000126	0.00159	CbGpPWpGaD
Mexiletine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000124	0.00157	CbGpPWpGaD
Mexiletine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000121	0.00154	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000118	0.00149	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—TYK2—multiple sclerosis	0.000116	0.00147	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—TYK2—multiple sclerosis	0.000116	0.00147	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—TYK2—multiple sclerosis	0.000112	0.00142	CbGpPWpGaD
Mexiletine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.000111	0.0014	CbGpPWpGaD
Mexiletine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000106	0.00135	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—MMP9—multiple sclerosis	9.95e-05	0.00126	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	9.27e-05	0.00117	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—MMP9—multiple sclerosis	9.14e-05	0.00116	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—MMP9—multiple sclerosis	9.14e-05	0.00116	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—TYK2—multiple sclerosis	9.02e-05	0.00114	CbGpPWpGaD
Mexiletine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.01e-05	0.00114	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—MMP9—multiple sclerosis	8.82e-05	0.00112	CbGpPWpGaD
Mexiletine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.62e-05	0.00109	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	8.56e-05	0.00108	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—TYK2—multiple sclerosis	8.29e-05	0.00105	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—TYK2—multiple sclerosis	8.29e-05	0.00105	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	8.27e-05	0.00105	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	8.24e-05	0.00104	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—MAPK1—multiple sclerosis	8.04e-05	0.00102	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—TYK2—multiple sclerosis	7.99e-05	0.00101	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—TYK2—multiple sclerosis	7.87e-05	0.000997	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—MAPK1—multiple sclerosis	7.39e-05	0.000936	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—MAPK1—multiple sclerosis	7.39e-05	0.000936	CbGpPWpGaD
Mexiletine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.3e-05	0.000925	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—MAPK1—multiple sclerosis	7.13e-05	0.000902	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—SRM—multiple sclerosis	7.11e-05	0.0009	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—MMP9—multiple sclerosis	7.1e-05	0.000899	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—SRM—multiple sclerosis	6.96e-05	0.000882	CbGpPWpGaD
Mexiletine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.95e-05	0.00088	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	6.91e-05	0.000875	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.62e-05	0.000839	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.62e-05	0.000839	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—POMC—multiple sclerosis	6.59e-05	0.000834	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—MMP9—multiple sclerosis	6.52e-05	0.000826	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MMP9—multiple sclerosis	6.52e-05	0.000826	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—POMC—multiple sclerosis	6.45e-05	0.000817	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	6.44e-05	0.000816	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	6.42e-05	0.000814	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—STAT3—multiple sclerosis	6.31e-05	0.000799	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	6.3e-05	0.000798	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—MMP9—multiple sclerosis	6.29e-05	0.000797	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MMP9—multiple sclerosis	6.2e-05	0.000785	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—IL6—multiple sclerosis	6.18e-05	0.000783	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	6e-05	0.00076	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	6e-05	0.00076	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—TGFB1—multiple sclerosis	5.85e-05	0.000741	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—STAT3—multiple sclerosis	5.8e-05	0.000735	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—STAT3—multiple sclerosis	5.8e-05	0.000735	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—MAPK1—multiple sclerosis	5.74e-05	0.000727	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—IL6—multiple sclerosis	5.68e-05	0.000719	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—IL6—multiple sclerosis	5.68e-05	0.000719	CbGpPWpGaD
Mexiletine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.64e-05	0.000714	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—TYK2—multiple sclerosis	5.62e-05	0.000711	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—STAT3—multiple sclerosis	5.59e-05	0.000708	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—IL6—multiple sclerosis	5.48e-05	0.000693	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—TNF—multiple sclerosis	5.46e-05	0.000692	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—TGFB1—multiple sclerosis	5.38e-05	0.000681	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—TGFB1—multiple sclerosis	5.38e-05	0.000681	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—MAPK1—multiple sclerosis	5.27e-05	0.000668	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MAPK1—multiple sclerosis	5.27e-05	0.000668	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—TGFB1—multiple sclerosis	5.19e-05	0.000657	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—MAPK1—multiple sclerosis	5.09e-05	0.000644	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—TNF—multiple sclerosis	5.02e-05	0.000636	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—TNF—multiple sclerosis	5.02e-05	0.000636	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MAPK1—multiple sclerosis	5.01e-05	0.000634	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	5.01e-05	0.000634	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	5.01e-05	0.000634	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SRM—multiple sclerosis	4.94e-05	0.000626	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	4.91e-05	0.000621	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	4.91e-05	0.000621	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—TNF—multiple sclerosis	4.84e-05	0.000613	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.58e-05	0.00058	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	4.58e-05	0.00058	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GPC5—multiple sclerosis	4.49e-05	0.000568	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MMP9—multiple sclerosis	4.42e-05	0.00056	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—IL6—multiple sclerosis	4.41e-05	0.000558	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SRM—multiple sclerosis	4.19e-05	0.00053	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—IL6—multiple sclerosis	4.05e-05	0.000513	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—IL6—multiple sclerosis	4.05e-05	0.000513	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—STAT3—multiple sclerosis	3.93e-05	0.000498	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—IL6—multiple sclerosis	3.91e-05	0.000495	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.88e-05	0.000491	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—IL6—multiple sclerosis	3.85e-05	0.000488	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.8e-05	0.000481	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—RRM1—multiple sclerosis	3.72e-05	0.000471	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	3.65e-05	0.000462	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	3.57e-05	0.000453	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	3.48e-05	0.000441	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	3.48e-05	0.000441	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—TNF—multiple sclerosis	3.4e-05	0.000431	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SRM—multiple sclerosis	3.23e-05	0.000409	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.18e-05	0.000403	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.99e-05	0.000379	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.95e-05	0.000373	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.95e-05	0.000373	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.88e-05	0.000365	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—IL6—multiple sclerosis	2.75e-05	0.000348	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.7e-05	0.000342	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.64e-05	0.000334	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.28e-05	0.000288	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.28e-05	0.000288	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.23e-05	0.000283	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.18e-05	0.000276	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—BCHE—multiple sclerosis	2.14e-05	0.00027	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.08e-05	0.000264	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.73e-05	0.00022	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.72e-05	0.000218	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.52e-05	0.000192	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.49e-05	0.000189	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.36e-05	0.000172	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—APOE—multiple sclerosis	1.31e-05	0.000166	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—APOE—multiple sclerosis	1.28e-05	0.000163	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.28e-05	0.000163	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—POMC—multiple sclerosis	1.13e-05	0.000143	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—POMC—multiple sclerosis	1.1e-05	0.00014	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ALB—multiple sclerosis	1.03e-05	0.00013	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ALB—multiple sclerosis	1.01e-05	0.000127	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—BCHE—multiple sclerosis	9.91e-06	0.000125	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—APOE—multiple sclerosis	9.11e-06	0.000115	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—POMC—multiple sclerosis	7.83e-06	9.92e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—APOE—multiple sclerosis	7.72e-06	9.78e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ALB—multiple sclerosis	7.14e-06	9.04e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—POMC—multiple sclerosis	6.63e-06	8.4e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ALB—multiple sclerosis	6.05e-06	7.66e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—APOE—multiple sclerosis	5.96e-06	7.55e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—POMC—multiple sclerosis	5.12e-06	6.48e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ALB—multiple sclerosis	4.67e-06	5.91e-05	CbGpPWpGaD
